The application of metagenomic next-generation sequencing for Angiostrongylus eosinophilic meningitis in a pediatric patient: A case report

Front Public Health. 2022 Oct 20:10:1003013. doi: 10.3389/fpubh.2022.1003013. eCollection 2022.

Abstract

Background: Angiostrongylus eosinophilic meningitis (AEM) is a rare yet emerging disease caused by Angiostrongylus cantonensis infection. Its atypical symptoms may delay the diagnosis and cause fatal outcomes, especially in the early stages of infection and among children.

Case presentation: Here we reported the use of metagenomic next-generation sequencing (mNGS) to facilitate the diagnosis and treatment of an 8-year-old boy with severe A. cantonensis infection. The mNGS tests consistently identified the infection of A. cantonensis prior to the detection by the immunologic method and confirmed it as AEM. Owing to the multidisciplinary team (MDT)-administrated treatments and close disease monitoring based on regular clinical tests and sequential mNGS tests, the patients eventually fully recovered from severe infectious conditions.

Conclusion: This case demonstrated the advantages of mNGS for early diagnosis of AEM in pediatric patients, highlighting its application for pan-pathogen detection, as well as disease monitoring for severe A. cantonensis infection.

Keywords: Angiostrongylus cantonensis; albendazole; doxycycline; eosinophilic meningitis; metagenomic next generation sequencing.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiostrongylus cantonensis* / genetics
  • Angiostrongylus*
  • Animals
  • Child
  • Eosinophilia* / diagnosis
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Male
  • Meningitis* / diagnosis

Substances

  • 2-aminoethylmethacrylate